Description
| Product Name | Format | CAT.No | Size |
| Pryidoxal Phosphate | Lyo | BXCPP6X3 | 6 x 3mg |
Product Description
The Biorex Diagnostics Pryidoxal Phosphate (PLP) Assay is a ready-to-use supplementary reagent designed to enhance the accuracy and reliability of ALT (IFCC) and AST (IFCC) enzymatic assays. Pryidoxal Phosphate, the biologically active form of vitamin B6, serves as an essential coenzyme for transaminase reactions. Its presence is critical for optimal enzyme activity, ensuring that measured alanine aminotransferase (ALT) and aspartate aminotransferase (AST) values accurately reflect true physiological levels. Without adequate cofactor availability, transaminase activity may be underestimated, potentially leading to misinterpretation of liver function results.
In clinical practice, accurate assessment of liver enzymes is fundamental for diagnosing and monitoring hepatic disorders, including hepatitis, cirrhosis, and drug-induced liver injury. Supplementation with Pryidoxal Phosphate ensures that enzymatic reactions proceed under optimal conditions, particularly in patient populations where vitamin B6 deficiency may be present, such as malnourished individuals, the elderly, or patients with chronic illness. By eliminating cofactor-related variability, the assay supports standardised and clinically reliable enzyme measurement across diverse patient groups.
Key Features
• Provides essential Pryidoxal Phosphate cofactor supplementation for ALT and AST assays
• Ensures optimal transaminase activity, preventing underestimation of enzyme levels
• Fully compatible with IFCC-standardised ALT and AST assay protocols
• Ready-to-use format simplifies laboratory workflow and reduces preparation time
• Suitable for use with automated clinical chemistry analysers and manual procedures
Benefits
The Biorex Pryidoxal Phosphate Assay enhances diagnostic confidence by ensuring complete coenzyme availability during ALT and AST testing. This results in accurate, reproducible, and clinically meaningful enzyme measurements, supporting reliable evaluation of liver function. By improving assay sensitivity and consistency, it enables earlier detection of hepatic abnormalities and more precise monitoring of disease progression or treatment response.
Its ready-to-use formulation improves operational efficiency, minimises handling errors, and ensures consistent performance across different laboratory platforms. This makes it particularly valuable in high-throughput hospital laboratories as well as specialised research settings focused on hepatology and metabolic studies.
In addition to routine diagnostics, the assay supports research into enzyme kinetics, nutritional deficiencies, and metabolic disorders where cofactor availability plays a significant role. Its ability to standardise transaminase measurement aligns with international testing guidelines, ensuring comparability of results across laboratories.
Overall, the Biorex Diagnostics Pryidoxal Phosphate Assay is an essential component of modern liver function testing. By delivering accurate, reliable, and standardised enzyme activity measurements, it supports improved clinical decision-making, enhances laboratory efficiency, and contributes to better patient outcomes in both diagnostic and research environments.
Contact Us for more information.